# PAZOPANIB HYDROCHLORIDE
> **ANDA219922** · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2025-09-04
## Drug
- **FDA Application Number:** ANDA219922
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PAZOPANIB HYDROCHLORIDE
- **Generic name:** PAZOPANIB HYDROCHLORIDE
- **Active ingredients:** PAZOPANIB HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TORRENT
- **Manufacturer:** Torrent Pharmaceuticals Limited
- **First approval:** 2025-09-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219922)
---
*AI Analytics · CC0 1.0*